Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limitedverified

TEVA

Price:

$16.81

Market Cap:

$19.04B

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treat...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

1982-02-16

Stock Exchange

NYSE

Ticker

TEVA

The PE Ratio as of July 2024 (TTM) for Teva Pharmaceutical Industries Limited (TEVA) is -40.02

According to Teva Pharmaceutical Industries Limited’s latest financial reports and current stock price. The company's current PE Ratio is -40.02. This represents a change of -1432.49% compared to the average of 3.00 of the last 4 quarters.

Teva Pharmaceutical Industries Limited (TEVA) Historical PE Ratio (quarterly & annually)

How has TEVA PE Ratio performed in the past?

The mean historical PE Ratio of Teva Pharmaceutical Industries Limited over the last ten years is 13.07. The current -40.02 PE Ratio has changed -30711.77% with respect to the historical average. Over the past ten years (40 quarters), TEVA's PE Ratio was at its highest in in the September 2015 quarter at 116.62. The PE Ratio was at its lowest in in the March 2019 quarter at -39.30.

Quarterly (TTM)
Annual

Average

13.07

Median

-1.92

Minimum

-20.90

Maximum

105.22

Teva Pharmaceutical Industries Limited (TEVA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Teva Pharmaceutical Industries Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 518.53%

Maximum Annual PE Ratio = 105.22

Minimum Annual Increase = -899.30%

Minimum Annual PE Ratio = -20.90

Quarterly (TTM)
Annual
YearPE RatioChange
2023-20.90385.76%
2022-4.30-120.32%
202121.17-899.30%
2020-2.65-75.26%
2019-10.7046.18%
2018-7.32518.53%
2017-1.18-101.12%
2016105.22197.74%
201535.34120.09%
201416.06-40.12%

Teva Pharmaceutical Industries Limited (TEVA) Average PE Ratio

How has TEVA PE Ratio performed in the past?

The current PE Ratio of Teva Pharmaceutical Industries Limited (TEVA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-1.34

5-year avg

-3.48

10-year avg

13.07

Teva Pharmaceutical Industries Limited (TEVA) PE Ratio vs. Peers

How is TEVA’s PE Ratio compared to its peers?

Teva Pharmaceutical Industries Limited’s PE Ratio is less than Haleon plc (29.29), greater than Bausch Health Companies Inc. (-134.58), less than Zoetis Inc. (34.21), less than Takeda Pharmaceutical Company Limited (22.91), less than Elanco Animal Health Incorporated (0), less than Viatris Inc. (-4.82), greater than Catalent, Inc. (-252.25), less than Mallinckrodt plc (-9.51), less than Shuttle Pharmaceuticals Holdings, Inc. (-0.00), less than Lifecore Biomedical, Inc. (-1.04), less than Lucy Scientific Discovery Inc. (-2.85), less than Tilray Brands, Inc. (-0.72), less than Canopy Growth Corporation (-4.25), less than Aurora Cannabis Inc. (-1.01), less than SNDL Inc. (-0.56), less than HEXO Corp. (-5.35), less than Cronos Group Inc. (-0.25), less than null (-15.58),

Build a custom stock screener for Teva Pharmaceutical Industries Limited (TEVA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Teva Pharmaceutical Industries Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Teva Pharmaceutical Industries Limited (TEVA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Teva Pharmaceutical Industries Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Teva Pharmaceutical Industries Limited's PE Ratio?

How is the PE Ratio calculated for Teva Pharmaceutical Industries Limited (TEVA)?

What is the highest PE Ratio for Teva Pharmaceutical Industries Limited (TEVA)?

What is the 3-year average PE Ratio for Teva Pharmaceutical Industries Limited (TEVA)?

What is the 5-year average PE Ratio for Teva Pharmaceutical Industries Limited (TEVA)?

How does the current PE Ratio for Teva Pharmaceutical Industries Limited (TEVA) compare to its historical average?